Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of [68Ga]Ga-PSMA-D5 and [68Ga]Ga-PSMA-11 in Prostate Cancer
NCT05955677Phase 1Unknown
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [68Ga]Ga-PSMA-D5 in prostate cancer (PCa), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Standardized Uptake Value at 30 days. Status: unknown.
02
Drugs
[68Ga]Ga-PSMA-D5
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05955677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05955677.